$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
Can the dose of alectinib be reduced due to serious side effects? How effective is alectinib?
2025-10-19 11:44:20
Check Details
How to alleviate the side effects of crizotinib? What are the precautions for crizotinib?
2025-10-19 11:44:20
Check Details
What are the common side effects of osimertinib and how to deal with them? How many years can I take osimertinib for the longest time?
2025-10-19 11:44:20
Check Details
What are the common adverse reactions of dacomitinib (Dozerun)? What to pay attention to
2025-10-19 11:44:20
Check Details
Can the dose of dacomitinib be adjusted due to serious side effects? What are the taboos and precautions?
2025-10-19 11:44:20
Check Details
What are the adverse reactions of bochitinib? What should you pay attention to during treatment
2025-10-19 11:44:20
Check Details
What are the side effects of bochitinib in treating lung cancer? How long does it take for resistance to bochitinib to develop?
2025-10-19 11:44:20
Check Details
What are the side effects and precautions of Tepotinib Hydrochloride Tablets?
2025-10-19 11:44:20
Check Details
What are the side effects of Aletinib (Aletinib)? What are the precautions
2025-10-19 11:44:20
Check Details
What are the common adverse reactions of osimertinib? What should you pay attention to when using it
2025-10-19 11:44:20
Check Details
What are the common adverse reactions of afatinib (Gitari)? What are the precautions
2025-10-19 11:44:20
Check Details
What are the side effects of gefitinib? What should we pay attention to
2025-10-19 11:44:20
Check Details
1
2
...
10148
10149
10150
10151
10152
10153
10154
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma